Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
Public ClinicalTrials.gov record NCT03850483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL-GROUP, DOSE RANGING STUDY TO ASSESS EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06700841 TOPICAL CREAM APPLIED ONCE OR TWICE DAILY FOR 12 WEEKS IN PARTICIPANTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, randomized, double blind, vehicle controlled, parallel group, multicenter study in participants with mild to moderate plaque psoriasis. The duration of study participation will be approximately 22 weeks, including up to a 6 week screening period, 12 week treatment period, and approximately 4 week follow up period. Approximately 280 participants are planned to be randomized into the study.
Study identification
- NCT ID
- NCT03850483
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 344 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2019 (Actual)
- Primary completion
- Apr 20, 2021 (Actual)
- Completion
- Apr 20, 2021 (Actual)
- Last update posted
- Jun 29, 2022
2019 – 2021
United States locations
- U.S. sites
- 38
- U.S. states
- 18
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Dermatology and Plastic Surgery/CCT | Scottsdale | Arizona | 85260 | — |
| Center for Dermatology and Plastic Surgery | Scottsdale | Arizona | 85260 | — |
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| California Skin Institute | Anaheim | California | 92801 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| New England Research Associates, LLC | Bridgeport | Connecticut | 06606 | — |
| Dermatology Physicians of Connecticut | Shelton | Connecticut | 06484 | — |
| Olympian Clinical Research | Clearwater | Florida | 33756 | — |
| Accel Research Sites - DeLand Clinical Research Unit | DeLand | Florida | 32720 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| MidState Skin Institute | Ocala | Florida | 34471 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Park Avenue Dermatology, PA | Orange Park | Florida | 32073 | — |
| Center for Clinical Studies | Tampa | Florida | 33613 | — |
| Dundee Dermatology | West Dundee | Illinois | 60118 | — |
| Ds Research | Clarksville | Indiana | 47129 | — |
| DS Research | Louisville | Kentucky | 40241 | — |
| Meridian Clinical Research, LLC | Baton Rouge | Louisiana | 70808 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| Bayside Dermatology Center | Bayside | New York | 11360 | — |
| Dermatology Consulting Services, PLLC | High Point | North Carolina | 27262 | — |
| M3 Wake Research, Inc. | Raleigh | North Carolina | 27612 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 74136 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Rivergate Dermatology Clinical Research | Goodlettsville | Tennessee | 37072 | — |
| Austin Institute for Clinical Research, Inc. | Austin | Texas | 78705 | — |
| studies in Dermatology, LLC | Cypress | Texas | 77433 | — |
| Center for Clinical Studies, LTD. LLP | Houston | Texas | 77004 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| Summit Clinical Research, LLC | Franklin | Virginia | 23851 | — |
| Virginia Dermatology and Skin Cancer Center | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03850483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03850483 live on ClinicalTrials.gov.